Investing.com -- Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) stock dropped 8.1% Thursday after the company announced the departure of its Chief Medical and Development Officer, Dr. Dana Pizzuti, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback